Ticker
STROCompany Name
SUTRO BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 262.36M | $ 19.59M | 7.47% |
3/31/2025 | $ 321.43M | $ 21.4M | 6.66% |
12/31/2024 | $ 387.21M | $ 23.15M | 5.98% |
9/30/2024 | $ 451.83M | $ 24.86M | 5.5% |
6/30/2024 | $ 489.04M | $ 26.53M | 5.42% |
3/31/2024 | $ 403.4M | $ 28.07M | 6.96% |
12/31/2023 | $ 470.74M | $ 33.63M | 7.15% |
9/30/2023 | $ 431.73M | $ 38.17M | 8.84% |
6/30/2023 | $ 464.9M | $ 42.66M | 9.18% |
3/31/2023 | $ 358.02M | $ 46.56M | 13.01% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for SUTRO BIOPHARMA INC is calculated as follows: Debt [ $ 24.41M ] / Assets [ $ 307.24M ]
(=) Debt to Assets [ 7.95% ]
Minimum
Jun 30, 2024
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.34% |
median | 21.09% |
std | 24.52% |